Involvement of p21(cip-1) and p27(kip-1) in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21(cip-1) in the maintenance of stem/progenitor cells in vivo

Charlie Mantel, Zaiming Luo, Jeff Canfield, Steve Braun, Chuxia Deng, Hal Broxmeyer

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Steel factor (SLF) is a hematopoietic cytokine that synergizes with other growth factors to induce a greatly enhanced proliferative state of hematopoietic progenitor cells and factor-dependent cell lines. Even though the in vivo importance of SLF in the maintenance and responsiveness of stem and progenitor cells is well documented, the molecular mechanisms involved in its synergistic effects are mainly unknown. Some factor-dependent myeloid cell lines respond to the synergistic proliferative effects of SLF plus other cytokines in a manner similar to that of normal myeloid progenitor cells from bone marrow and cord blood. We show here that SLF can synergize with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce an enhanced phosphorylation of the retinoblastoma gene product and a synergistic increase in the total intracellular protein level of the cyclin-dependent kinase inhibitor, p21(cip-1), which is correlated with a simultaneous decrease in p27(kip-1) in the human factor-dependent myeloid cell line, M07e. Moreover, these cytokines synergize to increase p21(cip-1) binding and decrease p27(kip-1) binding to cyclin-dependent kinase-2 (cdk2), an enzyme required for normal cell cycle progression; these inverse events correlated with increased cdk2 kinase activity. It is also shown that exogenous purified p21(cip-1) can displace p27(kip-1) already bound to cdk2 in vitro. These data implicate increased p21(cip-1) and decreased p27(kip-1) intracellular concentrations and their stoichiometric interplay in the enhanced proliferative status of cells stimulated by the combination of SLF and GM- CSF. In support of these findings, it is shown that hematopoietic progenitor cells from mice lacking p21(cip-1) are defective in SLF synergistic proliferative response in vitro. Moreover, the cycling status of marrow and spleen progenitors and absolute numbers of marrow progenitors were significantly decreased in the p21(cip-1) -/-, compared with the +/+ mice. We conclude that the cdk threshold regulators p21(cip-1) and p27(kip-1) play a critical role in the normal mitogenic response of M07e cells and murine myeloid progenitor cells to these cytokines and particularly in the SLF synergistic proliferative response that is important to the normal maintenance of the stem/progenitor cell compartment.

Original languageEnglish
Pages (from-to)3710-3719
Number of pages10
JournalBlood
Volume88
Issue number10
StatePublished - Nov 15 1996

Fingerprint

Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Stem Cell Factor
Stem cells
Stem Cells
Maintenance
Cyclin-Dependent Kinase 2
Cells
Cytokines
Myeloid Progenitor Cells
Bone Marrow
Myeloid Cells
Granulocyte-Macrophage Colony-Stimulating Factor
Hematopoietic Stem Cells
Cell Line
Retinoblastoma Genes
Phosphorylation
Human engineering
In Vitro Techniques
Fetal Blood

ASJC Scopus subject areas

  • Hematology

Cite this

Involvement of p21(cip-1) and p27(kip-1) in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21(cip-1) in the maintenance of stem/progenitor cells in vivo. / Mantel, Charlie; Luo, Zaiming; Canfield, Jeff; Braun, Steve; Deng, Chuxia; Broxmeyer, Hal.

In: Blood, Vol. 88, No. 10, 15.11.1996, p. 3710-3719.

Research output: Contribution to journalArticle

@article{dfff643ec3a84bdaac100746e056d59f,
title = "Involvement of p21(cip-1) and p27(kip-1) in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21(cip-1) in the maintenance of stem/progenitor cells in vivo",
abstract = "Steel factor (SLF) is a hematopoietic cytokine that synergizes with other growth factors to induce a greatly enhanced proliferative state of hematopoietic progenitor cells and factor-dependent cell lines. Even though the in vivo importance of SLF in the maintenance and responsiveness of stem and progenitor cells is well documented, the molecular mechanisms involved in its synergistic effects are mainly unknown. Some factor-dependent myeloid cell lines respond to the synergistic proliferative effects of SLF plus other cytokines in a manner similar to that of normal myeloid progenitor cells from bone marrow and cord blood. We show here that SLF can synergize with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce an enhanced phosphorylation of the retinoblastoma gene product and a synergistic increase in the total intracellular protein level of the cyclin-dependent kinase inhibitor, p21(cip-1), which is correlated with a simultaneous decrease in p27(kip-1) in the human factor-dependent myeloid cell line, M07e. Moreover, these cytokines synergize to increase p21(cip-1) binding and decrease p27(kip-1) binding to cyclin-dependent kinase-2 (cdk2), an enzyme required for normal cell cycle progression; these inverse events correlated with increased cdk2 kinase activity. It is also shown that exogenous purified p21(cip-1) can displace p27(kip-1) already bound to cdk2 in vitro. These data implicate increased p21(cip-1) and decreased p27(kip-1) intracellular concentrations and their stoichiometric interplay in the enhanced proliferative status of cells stimulated by the combination of SLF and GM- CSF. In support of these findings, it is shown that hematopoietic progenitor cells from mice lacking p21(cip-1) are defective in SLF synergistic proliferative response in vitro. Moreover, the cycling status of marrow and spleen progenitors and absolute numbers of marrow progenitors were significantly decreased in the p21(cip-1) -/-, compared with the +/+ mice. We conclude that the cdk threshold regulators p21(cip-1) and p27(kip-1) play a critical role in the normal mitogenic response of M07e cells and murine myeloid progenitor cells to these cytokines and particularly in the SLF synergistic proliferative response that is important to the normal maintenance of the stem/progenitor cell compartment.",
author = "Charlie Mantel and Zaiming Luo and Jeff Canfield and Steve Braun and Chuxia Deng and Hal Broxmeyer",
year = "1996",
month = "11",
day = "15",
language = "English",
volume = "88",
pages = "3710--3719",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "10",

}

TY - JOUR

T1 - Involvement of p21(cip-1) and p27(kip-1) in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21(cip-1) in the maintenance of stem/progenitor cells in vivo

AU - Mantel, Charlie

AU - Luo, Zaiming

AU - Canfield, Jeff

AU - Braun, Steve

AU - Deng, Chuxia

AU - Broxmeyer, Hal

PY - 1996/11/15

Y1 - 1996/11/15

N2 - Steel factor (SLF) is a hematopoietic cytokine that synergizes with other growth factors to induce a greatly enhanced proliferative state of hematopoietic progenitor cells and factor-dependent cell lines. Even though the in vivo importance of SLF in the maintenance and responsiveness of stem and progenitor cells is well documented, the molecular mechanisms involved in its synergistic effects are mainly unknown. Some factor-dependent myeloid cell lines respond to the synergistic proliferative effects of SLF plus other cytokines in a manner similar to that of normal myeloid progenitor cells from bone marrow and cord blood. We show here that SLF can synergize with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce an enhanced phosphorylation of the retinoblastoma gene product and a synergistic increase in the total intracellular protein level of the cyclin-dependent kinase inhibitor, p21(cip-1), which is correlated with a simultaneous decrease in p27(kip-1) in the human factor-dependent myeloid cell line, M07e. Moreover, these cytokines synergize to increase p21(cip-1) binding and decrease p27(kip-1) binding to cyclin-dependent kinase-2 (cdk2), an enzyme required for normal cell cycle progression; these inverse events correlated with increased cdk2 kinase activity. It is also shown that exogenous purified p21(cip-1) can displace p27(kip-1) already bound to cdk2 in vitro. These data implicate increased p21(cip-1) and decreased p27(kip-1) intracellular concentrations and their stoichiometric interplay in the enhanced proliferative status of cells stimulated by the combination of SLF and GM- CSF. In support of these findings, it is shown that hematopoietic progenitor cells from mice lacking p21(cip-1) are defective in SLF synergistic proliferative response in vitro. Moreover, the cycling status of marrow and spleen progenitors and absolute numbers of marrow progenitors were significantly decreased in the p21(cip-1) -/-, compared with the +/+ mice. We conclude that the cdk threshold regulators p21(cip-1) and p27(kip-1) play a critical role in the normal mitogenic response of M07e cells and murine myeloid progenitor cells to these cytokines and particularly in the SLF synergistic proliferative response that is important to the normal maintenance of the stem/progenitor cell compartment.

AB - Steel factor (SLF) is a hematopoietic cytokine that synergizes with other growth factors to induce a greatly enhanced proliferative state of hematopoietic progenitor cells and factor-dependent cell lines. Even though the in vivo importance of SLF in the maintenance and responsiveness of stem and progenitor cells is well documented, the molecular mechanisms involved in its synergistic effects are mainly unknown. Some factor-dependent myeloid cell lines respond to the synergistic proliferative effects of SLF plus other cytokines in a manner similar to that of normal myeloid progenitor cells from bone marrow and cord blood. We show here that SLF can synergize with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce an enhanced phosphorylation of the retinoblastoma gene product and a synergistic increase in the total intracellular protein level of the cyclin-dependent kinase inhibitor, p21(cip-1), which is correlated with a simultaneous decrease in p27(kip-1) in the human factor-dependent myeloid cell line, M07e. Moreover, these cytokines synergize to increase p21(cip-1) binding and decrease p27(kip-1) binding to cyclin-dependent kinase-2 (cdk2), an enzyme required for normal cell cycle progression; these inverse events correlated with increased cdk2 kinase activity. It is also shown that exogenous purified p21(cip-1) can displace p27(kip-1) already bound to cdk2 in vitro. These data implicate increased p21(cip-1) and decreased p27(kip-1) intracellular concentrations and their stoichiometric interplay in the enhanced proliferative status of cells stimulated by the combination of SLF and GM- CSF. In support of these findings, it is shown that hematopoietic progenitor cells from mice lacking p21(cip-1) are defective in SLF synergistic proliferative response in vitro. Moreover, the cycling status of marrow and spleen progenitors and absolute numbers of marrow progenitors were significantly decreased in the p21(cip-1) -/-, compared with the +/+ mice. We conclude that the cdk threshold regulators p21(cip-1) and p27(kip-1) play a critical role in the normal mitogenic response of M07e cells and murine myeloid progenitor cells to these cytokines and particularly in the SLF synergistic proliferative response that is important to the normal maintenance of the stem/progenitor cell compartment.

UR - http://www.scopus.com/inward/record.url?scp=0029661875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029661875&partnerID=8YFLogxK

M3 - Article

C2 - 8916935

AN - SCOPUS:0029661875

VL - 88

SP - 3710

EP - 3719

JO - Blood

JF - Blood

SN - 0006-4971

IS - 10

ER -